Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant adeno-associated virus-mediated expression of fractalkine for treatment of neuroinflammatory and neurodegenerative diseases

Recombinant adeno-associated virus-mediated expression of fractalkine for treatment of neuroinflammatory and neurodegenerative diseases

US Patent 10815285 · Granted Oct 27, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of reducing cognitive impairment and learning and memory deficits caused2025
Modified UBE3A gene for a gene therapy approach for angelman syndrome2022
Exosomes from human adipose-derived stem cells for the treatment of brain injury2020
Arginine deiminase gene therapy for disordered proteins2019
Methods of treating epilepsy using neural stem cells that express nanog, SSEA-4,2019
Compositions and methods of improving cognitive performance2017
Method of treating neurological disorders using long non-coding RNAs2017
Combined effects of nutrients on proliferation of stem cells2013
I-pheny 1-3,4-dihydropyrimidin-2(1H)-one derivatives and their use2012
Dihydropyridine derivatives for use as human neutrophil elastase inhibitors2010
Pyrimidinone derivatives as therapeutic agents against acute and chronic inflamm2010
1-phenyl1-3,4-dihydropyrimidin-2(1H)-one derivatives and their use2009